| Literature DB >> 34966477 |
Bianca Augusta Oroian1, Alin Ciobica2, Daniel Timofte3, Cristinel Stefanescu3, Ionela Lăcrămioara Serban3.
Abstract
Posttraumatic stress disorder (PTSD) represents a pressing and generally invalidating syndrome that is triggered by a terrifying or stressful experience, relying on recurrently reliving the traumatic event feelings associated to it, which is subsequently linked to ongoing activations of stress-related neurobiological pathways and is often associated with neurodegeneration. In this paper, we examine what lies beneath this disorder, reviewing evidence that connects PTSD with a wide array of mechanisms and its intertwined pathways that can lead to the decompensation of different pathologies, such as cardiovascular disease, gastrointestinal ailments, autoimmune disorders, and endocrine diseases. Also, the significance of the oxidative stress in this frame of reference is debated. Thus, knowing and identifying the main features of the distressing experience, the circumstances around it, as well as the neuropsychological and emotional characteristics of people prone to develop PTSD after going through disturbing incidents can offer an opportunity to anticipate the development of potential destructive consequences in several psychological dimensions: cognitive, affective, relational, behavioral, and somatic. We can also observe more closely the intricate connections of the disorder to other pathologies and their underlying mechanisms such as inflammation, oxidative stress, bacterial overgrowth syndrome, irritable bowel syndrome, metabolic disorders, oxytocin, and cortisol in order to understand it better and to optimize the course of treatment and its management. The complex foundation PTSD possesses is supported by the existing clinical, preclinical, and experimental data encompassed in the current review. Different biological systems and processes such as the hypothalamic-pituitary-adrenal axis, sympathetic nervous system, oxidative stress, inflammation, and microbiome suffer modifications and changes when it comes to PTSD; that is why targeted therapies exert tremendous alleviations of symptoms in patients diagnosed with this disorder. Therefore, this implies that PTSD is not restricted to the psychiatric domain and should be viewed as a systemic condition.Entities:
Mesh:
Year: 2021 PMID: 34966477 PMCID: PMC8712172 DOI: 10.1155/2021/5599265
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Behavior and somatic adjustment in the stress process [8].
| Adjustment of behavior | Adjustment of somatic processes |
|---|---|
| Modifying the behavior according to the situation at hand | Redirecting the energetic force of the systems involved according to their necessity |
| Altered sensory threshold | Directing the needed compounds (O2, carbohydrates, lipids, proteins, vitamins, water, and minerals) towards CNS and other involved areas |
| Sharpened memory and sensation | Modified cardiac activity; elevation of blood pressure, heart rate, and force of cardiac contraction |
| A high sense of arousal and awareness | Elevated respiratory rate |
| Increased cognitive functions, attentiveness, and concentration | Increased gluconeogenesis+lipolysis |
| Suppression of behaviors related to nutrition (obtaining/consuming food) | Removing toxic compounds |
| Inhibition of reproductive functions | Freezing reproductive and growth axes |
| Inhibition of gastric motility; greater movement in the colon | Limiting the reaction to stress |
| Limiting the reaction to stress | Containment of inflammatory/immune response |
| Stress-induced analgesia | Release of norepinephrine and epinephrine |
Figure 1Symptoms of PTSD [16].
Figure 2The gut-brain axis and principal mechanisms of bidirectional communication that happens amid the central and the enteric nervous system [33, 34].
Figure 3Polyphenol inhibition of neurodegenerative mechanisms [91].